Teva Recalls Fluoxetine Capsules Due to Chemical Contamination and Odor
Teva Pharmaceuticals USA is recalling 72,356 bottles of Fluoxetine Capsules, 10 mg, due to a customer complaint trend regarding capsule odor.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, but the source text does not report any illnesses, injuries, or hospitalizations, and the hazard is based on a complaint trend regarding odor rather than a confirmed high-risk pathogen or structural defect.
Plain-English summary
Teva Pharmaceuticals USA is recalling 72,356 bottles of Fluoxetine Capsules USP, 10 mg, 100-count bottles. The product is prescription-only and was manufactured in Poland by Pliva Krakow Pharmaceutical Company S.A. for Teva Pharmaceuticals USA. The affected lots are 6A211158, 6A211159, and 6A211163, with an expiration date of 11/15.
The recall was initiated due to a customer complaint trend regarding capsule odor, which the FDA classifies as a chemical contamination issue. The agency has classified this recall as Class II, indicating a situation in which there is a reasonable probability that the use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences.
The affected product was distributed nationwide and in Puerto Rico. Consumers and healthcare providers should check their inventory for the specific lot numbers and expiration date listed above. If the product is found, it should be returned to the pharmacy or point of purchase for a refund or replacement.
The recalled product
- Product
- FLUOXETINE (FLUOXETINE)
- Brand
- FLUOXETINE
- Manufacturer
- Teva Pharmaceuticals USA
- Category
- Drug — Prescription Medication
- Affected units
- 72,356
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: 6A211158
- 6A211159
- 6A211163
- Exp 11/15
UPCs (1)
- 350111647015
Distribution
Part of a larger recall action
This product is one of 2 recalled by Teva Pharmaceuticals USA under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · FLUOXETINE
- HighFluoxetine Tablets USP 20 mg Recalled for N-Nitroso Contamination
FDA (Drugs) · 2025-06-11
- SevereFluoxetine Tablets 20 mg Recalled for N-Nitroso Impurity
FDA (Drugs) · 2025-06-11
- SevereTeva Recalls Fluoxetine Capsules Due to Residual Solvent Impurity
FDA (Drugs) · 2015-05-06
- ModerateTeva Recalls Fluoxetine Capsules Due to Residual Solvent Impurity
FDA (Drugs) · 2015-05-06
- ModerateLegacy Pharmaceutical Packaging Recalls Fluoxetine Capsules Due to Odor Complaints
FDA (Drugs) · 2014-05-07
Same manufacturer · Teva Pharmaceuticals USA
See all →- ModerateDoxylamine Succinate and Pyridoxine Hydrochloride Tablets Recalled for Failed Dissolution
FDA (Drugs) · 2022-02-09
- LowPrescription Drug Recall: Mimvey Mislabeling by Teva Pharmaceuticals
FDA (Drugs) · 2022-02-09
- ModerateTretinoin Capsules 10 mg Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2022-02-09
- LowMimvey Estradiol/Norethindrone Prescription Drug Mislabeling Recall
FDA (Drugs) · 2022-02-09
- ModerateBrinzolamide Ophthalmic Suspension recalled for defective container caps
FDA (Drugs) · 2022-01-26
Same hazard · chemical contamination
See all →- SevereAmerican Regent Recalls Acetylcysteine Solution Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereGas-X Extra Strength softgels contaminated with propylene glycol machine coolant
FDA (Drugs) · 2026-06-17
- HighDragonfly Thai ginger powder may be contaminated with lead
FDA (Food) · 2026-06-17
- SevereNaproxen Oral Suspension Recalled for Lead and Lithium Contamination
FDA (Drugs) · 2026-05-13
- HighFarmHouse Fresh benzoyl peroxide night lotion recalled over benzene contamination
FDA (Drugs) · 2026-04-22